General Range
FORIXONE TZ
Price on request/100 · MOQ 100 boxes
FORIXONE TZ Injection by Fortune Labs contains Ceftriaxone 250 mg and Tazobactam 31.25 mg, an antibiotic combination formulated for treating selected bacterial infections. Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam helps protect it against certain bacterial beta-lactamase enzymes. FORIXONE TZ may be prescribed for susceptible respiratory tract, urinary tract, and skin infections when clinically appropriate. Available in a 281.25 mg single-dose vial, this product is part of Fortune Labs' injectable pharmaceutical portfolio. Fortune Labs offers Injection PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. This prescription injection must be administered by a qualified healthcare professional.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Ceftriaxone 250 mg + Tazobactam 31.25 mg
- Packaging Type
- Glass Vial with Outer Carton
- Packaging Size
- —
- Dosage Form
- Injection
- Treatment
- Selected bacterial respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial infections
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
